Keith Wesnes
Impact in
- Complementary and alternative medicine top 0.05%
- Ginkgo biloba and Cashew Applications
- Psychiatry and Mental health top 0.2%
- Dementia and Cognitive Impairment Research
Papers in
-
- Dementia and Cognitive Impairment Research 63
- Attention Deficit Hyperactivity Disorder 17
-
- Memory and Neural Mechanisms 35
- Co-authors
- Andrew Scholey (46 shared papers)David M. Warburton (13 shared papers)David O. Kennedy (21 shared papers)Ian G. McKeith (20 shared papers)Mark Moss (14 shared papers)Clive Ballard (32 shared papers)John T. O’Brien (14 shared papers)C.F. Haskell (8 shared papers)
- Journals
- Psychopharmacology (17 papers)Journal of Psychopharmacology (16 papers)European Neuropsychopharmacology (15 papers)International Journal of Geriatric Psychiatry (14 papers)Human Psychopharmacology Clinical and Experimental (13 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Keith Wesnes
316 papers receiving 15.9k citations
Keith Wesnes's Hit Papers
Peers
Comparison fields: 5 of 192
- Complementary and alternative medicine 2.1k
- Psychiatry and Mental health 3.8k
- Sensory Systems 1.0k
- Cognitive Neuroscience 3.7k
- Biological Psychiatry 472
Countries citing papers authored by Keith Wesnes
This map shows the geographic impact of Keith Wesnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Wesnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Wesnes more than expected).
Fields of papers citing papers by Keith Wesnes
This network shows the impact of papers produced by Keith Wesnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Wesnes. The network helps show where Keith Wesnes may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Wesnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 321 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study Hit paper breakdown → | 2000 | 744 |
| 2 | 2002 | 351 | |
| 3 | 2003 | 332 | |
| 4 | Characterizing mild cognitive impairment in incident Parkinson disease Hit paper breakdown → | 2013 | 330 |
| 5 | 1984 | 283 | |
| 6 | 2000 | 265 | |
| 7 | 2005 | 263 | |
| 8 | 2000 | 262 | |
| 9 | 2003 | 230 | |
| 10 | 2015 | 230 | |
| 11 | 2004 | 207 | |
| 12 | 2007 | 200 | |
| 13 | 1983 | 199 | |
| 14 | 1983 | 198 | |
| 15 | 2002 | 190 | |
| 16 | 2000 | 184 | |
| 17 | 1998 | 181 | |
| 18 | 2002 | 178 | |
| 19 | 2012 | 175 | |
| 20 | 2002 | 170 |
About Keith Wesnes
Keith Wesnes is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience, Pharmacology, Complementary and alternative medicine and Physiology, having authored 321 papers that have together received 16.8k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (63 papers), Memory and Neural Mechanisms (35 papers), Intensive Care Unit Cognitive Disorders (26 papers), Ginkgo biloba and Cashew Applications (23 papers), Neurological Disease Mechanisms and Treatments (22 papers), Blood Pressure and Hypertension Studies (18 papers), Treatment of Major Depression (18 papers) and Attention Deficit Hyperactivity Disorder (17 papers). The work is most often cited by research in Complementary and alternative medicine (2.1k citations), Psychiatry and Mental health (3.8k citations), Sensory Systems (1.0k citations), Cognitive Neuroscience (3.7k citations) and Biological Psychiatry (472 citations). Keith Wesnes has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Andrew Scholey, David M. Warburton, David O. Kennedy, Ian G. McKeith, Mark Moss, Clive Ballard, John T. O’Brien, C.F. Haskell, Paul Simpson and Murat Emre. Their work appears in journals such as Psychopharmacology, Journal of Psychopharmacology, European Neuropsychopharmacology, International Journal of Geriatric Psychiatry and Human Psychopharmacology Clinical and Experimental.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.